351 related articles for article (PubMed ID: 30681400)
1. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India.
Muniaraj M; Rajamannar V
Hum Vaccin Immunother; 2019; 15(4):834-840. PubMed ID: 30681400
[TBL] [Abstract][Full Text] [Related]
2. Assessment of effectiveness of Japanese encephalitis vaccination in West Bengal, India using sample positivity rate as an alternate measure.
Chakraborty D; Banerjee S; Maji D; Dey TK; Vaitheeswaran K; Mondal P; Biswas P; Debnath F; Chatterjee P
J Vector Borne Dis; 2021; 58(3):199-205. PubMed ID: 35170456
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study.
Tandale BV; Khan SA; Kushwaha KP; Rahman H; Gore MM;
J Infect Public Health; 2018; 11(5):713-719. PubMed ID: 29703709
[TBL] [Abstract][Full Text] [Related]
4. Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.
Upreti SR; Lindsey NP; Bohara R; Choudhary GR; Shakya S; Gautam M; Giri JN; Fischer M; Hills SL
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005866. PubMed ID: 28934197
[TBL] [Abstract][Full Text] [Related]
5. Japanese encephalitis vaccine: need of the hour in endemic states of India.
Verma R
Hum Vaccin Immunother; 2012 Apr; 8(4):491-3. PubMed ID: 22370517
[TBL] [Abstract][Full Text] [Related]
6. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Japanese Encephalitis and Acute Encephalitis Syndrome Hospitalizations in the Medium-Endemic Region in Central India.
Tandale BV; Deshmukh PS; Tomar SJ; Narang R; Qazi MS; Goteti Venkata P; Jain M; Jain D; Guduru VK; Jain J; Gosavi RV; Valupadas CS; Deshmukh PR; Raut AV; Narlawar UW; Jha PK; Bondre VP; Sapkal GN; Damle RG; Khude PM; Niswade AK; Talapalliwar M; Rathod P; Balla PS; Muttineni PK; Kalepally Janakiram KK; Rajderkar SS
J Epidemiol Glob Health; 2023 Jun; 13(2):173-179. PubMed ID: 37162636
[TBL] [Abstract][Full Text] [Related]
10. Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine.
Hills SL; Van Keulen A; Feser J; Panella A; Letson GW; Staples JE; Marfin AA; Brault AC
Am J Trop Med Hyg; 2020 Nov; 104(2):576-579. PubMed ID: 33236716
[TBL] [Abstract][Full Text] [Related]
11. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
12. Vaccination Policy for Japanese Encephalitis in India: Tread with Caution!
Vashishtha VM; Ramachandran VG
Indian Pediatr; 2015 Oct; 52(10):837-9. PubMed ID: 26499003
[TBL] [Abstract][Full Text] [Related]
13. Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children.
Wang R; Xie L; Gao N; Fan D; Chen H; Wang P; Zhou H; An J
Virol Sin; 2019 Jun; 34(3):243-252. PubMed ID: 30911897
[TBL] [Abstract][Full Text] [Related]
14. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
15. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
Moore SM
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009385. PubMed ID: 34644296
[TBL] [Abstract][Full Text] [Related]
16. Duration of seroprotection of the live attenuated SA-14-14-2 Japanese encephalitis vaccine in children in India.
Preethi L; Alina MS; Chandran L; Asvin S; Jagadeesan M; Vijayakumar TM; Chitra V; Pandey AK; Reddy MM; Misra BR; Kant R; Bhukya PL; Deshpande GR; Abraham P; Sapkal G; Zaman K
J Travel Med; 2023 Apr; 30(2):. PubMed ID: 36495206
[TBL] [Abstract][Full Text] [Related]
17. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
18. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
Ginsburg AS; Meghani A; Halstead SB; Yaich M
Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
[TBL] [Abstract][Full Text] [Related]
19. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.
Murhekar MV; Oak C; Ranjan P; Kanagasabai K; Shinde S; Pandey AK; Mittal M; Gore M; Mehendale SM
Indian J Med Res; 2017 Jan; 145(1):63-69. PubMed ID: 28574016
[TBL] [Abstract][Full Text] [Related]
20. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.
Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P
Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
